149 related articles for article (PubMed ID: 37898642)
1. HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target.
Capone E; Tryggvason T; Cela I; Dufrusine B; Pinti M; Del Pizzo F; Gunnarsdottir HS; Grottola T; De Laurenzi V; Iacobelli S; Lattanzio R; Sala G
Cell Death Discov; 2023 Oct; 9(1):400. PubMed ID: 37898642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors in Stage IV Colorectal Cancer Patients With Resection of Liver and/or Pulmonary Metastases: A Population-Based Cohort Study.
Peng P; Luan Y; Sun P; Wang L; Zeng X; Wang Y; Cai X; Ren P; Yu Y; Liu Q; Ma H; Chang H; Song B; Fan X; Chen Y
Front Oncol; 2022; 12():850937. PubMed ID: 35372009
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
[No Abstract] [Full Text] [Related]
5. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases.
Yun S; Lee S; Lee HY; Oh HJ; Kwak Y; Lee HS
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208855
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.
Langan RC; Mullinax JE; Ray S; Raiji MT; Schaub N; Xin HW; Koizumi T; Steinberg SM; Anderson A; Wiegand G; Butcher D; Anver M; Bilchik AJ; Stojadinovic A; Rudloff U; Avital I
J Cancer; 2012; 3():231-40. PubMed ID: 22670157
[TBL] [Abstract][Full Text] [Related]
10. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
11. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of increased lymph node yield in colorectal cancer patients with synchronous liver metastasis: a population-based retrospective study of the US database and a Chinese registry.
Jiao S; Guan X; Zhang W; Wei R; Wang G; Wang X
Int J Surg; 2023 Jul; 109(7):1932-1940. PubMed ID: 37037584
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies.
Yin L; Li J; Ma D; Li D; Sun Y
Oncol Lett; 2020 May; 19(5):3558-3566. PubMed ID: 32269630
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer.
Huang CJ; Teng HW; Chien CC; Lin JK; Yang SH
PLoS One; 2014; 8(6):e65117. PubMed ID: 23755178
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
17. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor.
Lim SW; Kim HR; Kim HY; Huh JW; Kim YJ; Shin JH; Suh SP; Ryang DW; Kim HR; Shin MG
Cell Oncol (Dordr); 2013 Jul; 36(4):311-21. PubMed ID: 23722824
[TBL] [Abstract][Full Text] [Related]
19. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
